ARPHION
Chicago
About ARPHION
Arphion creates non-invasive diagnostics for oral cancers and other benign diseases. They utilize miRNA markers from cheek swabs to diagnose oral squamous cell carcinomas. Arphion provides its clients with tests as a Laboratory Developed Test (LDT) through a CLIA-certified laboratory to market their products without submission to the FDA for approval or clearance. Arphion was founded by Dr. Guy Adami, Ph.D. in Illinois, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $225.0K
- Last round: Grant (Mar 2013)
- Website: arphiondx.com
Industries & Categories
Consulting, Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/arphion-1425730 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.